[
  {
    "ts": null,
    "headline": "How the Narrative for Baxter International Is Evolving Amid Leadership Changes and Mixed Analyst Views",
    "summary": "Baxter International’s fair value estimate has shifted only marginally higher, while the discount rate has edged up. This reflects subtle changes in the market’s outlook for the stock. Recent analyst commentary reveals a mixed narrative, with some experts optimistic about the company’s ongoing transformation and leadership changes, while others remain cautious due to slowing growth and profitability pressures. Stay tuned to discover how investors can monitor these evolving perspectives and...",
    "url": "https://finnhub.io/api/news?id=59e5f471dc9c63a01fdb4e12193e12f168eabea2ac3467fe0f1d6831501a6cfd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759752942,
      "headline": "How the Narrative for Baxter International Is Evolving Amid Leadership Changes and Mixed Analyst Views",
      "id": 136990133,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Baxter International’s fair value estimate has shifted only marginally higher, while the discount rate has edged up. This reflects subtle changes in the market’s outlook for the stock. Recent analyst commentary reveals a mixed narrative, with some experts optimistic about the company’s ongoing transformation and leadership changes, while others remain cautious due to slowing growth and profitability pressures. Stay tuned to discover how investors can monitor these evolving perspectives and...",
      "url": "https://finnhub.io/api/news?id=59e5f471dc9c63a01fdb4e12193e12f168eabea2ac3467fe0f1d6831501a6cfd"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock with Exciting Potential and 2 Facing Challenges",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
    "url": "https://finnhub.io/api/news?id=2d4f4c64861ab1288967f6a6fcfe31f3dd08f2dddd748dcccbf5d560c66c7040",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759725756,
      "headline": "1 Healthcare Stock with Exciting Potential and 2 Facing Challenges",
      "id": 136989647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
      "url": "https://finnhub.io/api/news?id=2d4f4c64861ab1288967f6a6fcfe31f3dd08f2dddd748dcccbf5d560c66c7040"
    }
  }
]